BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6511805)

  • 1. Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular).
    Hansmann ML; Zwingers T; Böske A; Löffler H; Lennert K
    J Cancer Res Clin Oncol; 1984; 108(3):321-30. PubMed ID: 6511805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hodgkin's nodular paragranuloma (nodular Hodgkin's disease, with lymphocytic predominance): apropos of 29 cases].
    Molina T; Diebold J
    Bull Cancer; 1987; 74(4):463-72. PubMed ID: 3663967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of nodular paragranuloma (Hodgkin's disease with lymphocytic predominance, nodular).
    Poppema S; Kaiserling E; Lennert K
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):57-63. PubMed ID: 500769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
    Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin's disease.
    Ferry JA; Zukerberg LR; Harris NL
    Am J Surg Pathol; 1992 Mar; 16(3):252-8. PubMed ID: 1599017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.
    van Grotel M; Lam KH; de Man R; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
    Leuk Lymphoma; 2006 Aug; 47(8):1504-10. PubMed ID: 16966260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.
    Rubio R
    Cancer; 1994 May; 73(9):2400-7. PubMed ID: 8168044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive transformation of germinal centers with and without association to Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Moubayed P
    Am J Clin Pathol; 1990 Feb; 93(2):219-26. PubMed ID: 2405631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
    Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
    Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study.
    Poppema S; Kaiserling E; Lennert K
    Histopathology; 1979 Jul; 3(4):295-308. PubMed ID: 468131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hodgkin's disease in Hong Kong Chinese.
    Liang R; Choi P; Todd D; Chan TK; Choy D; Ho F
    Hematol Oncol; 1989; 7(6):395-403. PubMed ID: 2807177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
    Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
    Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma].
    Yong WB; Wang H; Zhu XM
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):91-3. PubMed ID: 7691489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
    Hull MC; Mendenhall NP; Colgan ME
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):161-6. PubMed ID: 11777634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.